A5017131768- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Digestive system and related health
- Colorectal Cancer Surgical Treatments
- Helicobacter pylori-related gastroenterology studies
- Cancer Immunotherapy and Biomarkers
- Genetic factors in colorectal cancer
- Cancer Diagnosis and Treatment
Institut Jules Bordet
2024
Université Libre de Bruxelles
2021-2024
Erasmus Hospital
2021
Zagazig University
2015
Immune checkpoint inhibitors and immune-related biomarkers are increasingly investigated in rectal cancer (RC). We retrospectively analysed PD-L1 expression diagnostic biopsy resection samples from RC patients treated at our centre between 2000 2020. immunostaining (22C3 clone) was evaluated according to tumour proportion (TPS), immune cell (ICS), the combined positive score (CPS). Eighty-three were included. At diagnosis, ≥1%/≥5% observed 15.4%/0%, 80.7%/37.4%, 69.2%/25.6% of based on TPS,...
Background and aim:The material of this study comprises 57 gastric biopsies including paraffin blocks selected from the archives Pathology Department, Faculty medicine, Zagazig University in addition to 10 freshly randomly endoscopic were obtained Endoscopy Unit Tropical Medicine department, Medicine, hospital period 2011-2013 examine expression CDX2,MUC2 MUC6 cases chronic gastritis, metaplasia, dysplasia cancer role these markers as predictors progression gastritis carcinoma.Methods:...